The Ticker: Discount Delays Vote on New CEO’s Compensation

Teva gets preliminary FDA nod for asthma treatment; TASE shares finish low.

Send in e-mailSend in e-mail
Eduardo Elsztain, above, and his partner Moti Ben-Moshe seem too busy squabbling to bring order to their unwieldy financial house.Credit: Daniel Bar On

Comments